867339-05-7

Basic information

• Product Name: N-(2-aminophenyl)-2-(2-isopropylphenoxy)acetamide
• Synonyms: N-(2-aminophenyl)-2-(2-isopropylphenoxy)acetamide
• CAS NO: 867339-05-7
• Molecular Weight: 284.358
• Mol File: 867339-05-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(2-aminophenyl)-2-(2-isopropylphenoxy)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-aminophenyl)-2-(2-isopropylphenoxy)acetamide(867339-05-7)
• EPA Substance Registry System: N-(2-aminophenyl)-2-(2-isopropylphenoxy)acetamide(867339-05-7)

Safety Data

• Hazardous Substances Data: 867339-05-7(Hazardous Substances Data)

Upstream product

• 88-69-7 2-(1-methylethyl)phenol 
• 444613-15-4 ethyl 2-(2-isopropylphenoxy)acetate 
• 25141-58-6 2-(2-isopropylphenoxy)acetic acid 
• 95-54-5 1,2-diamino-benzene 

Relevant articles and documents

Targeting HIF-1α by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression

Background: Hypoxic microenvironment is a common feature of solid tumors, which leads to the promotion of cancer. The transcription factor, HIF-1α, expressed under hypoxic conditions stimulates tumor angiogenesis, favoring HIF-1α as a promising anticancer agent. On the other hand, synthetic Indolephenoxyacetamide derivatives are known for their pharmacological potentiality. With this background here, we have synthesized, characterized, and validated the new IPA (8a–n) analogs for anti-tumor activity. Methods: The new series of IPA (8a–n) were synthesized through a multi-step reaction sequence and characterized based on the different spectroscopic analysis FT-IR, 1H, 13C NMR, mass spectra, and elemental analyses. Cell-based screening of IPA (8a–n) was assessed by MTT assay. Anti-angiogenic efficacy of IPA (8k) validated through CAM, Rat corneal, tube formation and migration assay. The underlying molecular mechanism is validated through zymogram and IB studies. The in vivo anti-tumor activity was measured in the DLA solid tumor model. Results: Screening for anti-proliferative studies inferred, IPA (8k) is a lead molecule with an IC50 value of ?5?μM. Anti-angiogenic assays revealed the angiopreventive activity through inhibition of HIF-1α and modulation downstream regulatory genes, VEGF, MMPs, and P53. The results are confirmative in an in vivo solid tumor model. Conclusion: The IPA (8k) is a potent anti-proliferative molecule with anti-angiogenic activity and specifically targets HIF1α, thereby modulates its downstream regulatory genes both in vitro and in vivo. The study provides scope for new target-specific drug development against HIF-1α for the treatment of solid tumors. Graphic abstract: [Figure not available: see fulltext.].

PTEN INHIBITORS

The therapeutic use of inhibitors of PTEN activity in the treatment of PTEN-mediated diseases, conditions, and injuries is disclosed.